Bio-fuels pioneer Lanzatech has achieved its largest capital-raising to date, announcing it has secured US$55.8 million in new capital from a combination of leading Malaysian state and private funders, along with existing investors in the US, China, and New Zealand.
With its scientific headquarters in Auckland, but headquartered in the US, Lanzatech is increasingly cited as an emerging leader in the fast-developing global bio-fuels industry, with strategic relationships ranging from China's most prestigious state science agency to the US Department of Defense's innovation arm.
The latest deal, described as its "Series C round'' of fundraising, comes ahead of a possible sharemarket listing as early as next year, most probably in the US or China.
The lead investor in this round of capital-raising adds a new dimension for Lanzatech by bringing on board the Malaysian Life Sciences Capital Fund as the lead participant. A partnership between the Malaysian Technology Development Corporation and San Francisco-based merchant bank Burrill & Co, the fund is closely linked to the country's state-led economic development strategy.
Also on board in this round are the Malaysian state oil company, Petronas, and Dialog Group, described as a specialist technical services provider to the petrochemical industry.